[go: up one dir, main page]

BR9909996B1 - composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto. - Google Patents

composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto.

Info

Publication number
BR9909996B1
BR9909996B1 BRPI9909996-9A BR9909996A BR9909996B1 BR 9909996 B1 BR9909996 B1 BR 9909996B1 BR 9909996 A BR9909996 A BR 9909996A BR 9909996 B1 BR9909996 B1 BR 9909996B1
Authority
BR
Brazil
Prior art keywords
compound
preparation
pharmaceutical formulation
pyridine derivative
imidazo pyridine
Prior art date
Application number
BRPI9909996-9A
Other languages
English (en)
Other versions
BR9909996A (pt
Inventor
Kosrat Amin
Michael Dahlstroem
Peter Nordberg
Ingemar Starke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BR9909996A publication Critical patent/BR9909996A/pt
Publication of BR9909996B1 publication Critical patent/BR9909996B1/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BRPI9909996-9A 1998-04-29 1999-04-23 composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto. BR9909996B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9801526A SE9801526D0 (sv) 1998-04-29 1998-04-29 New compounds
PCT/SE1999/000663 WO1999055706A1 (en) 1998-04-29 1999-04-23 Imidazo pyridine derivatives which inhibit gastric acid secretion

Publications (2)

Publication Number Publication Date
BR9909996A BR9909996A (pt) 2000-12-26
BR9909996B1 true BR9909996B1 (pt) 2010-08-24

Family

ID=20411154

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI9909996-9A BR9909996B1 (pt) 1998-04-29 1999-04-23 composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto.
BRPI9909995-0A BR9909995B1 (pt) 1998-04-29 1999-04-23 composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto.

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI9909995-0A BR9909995B1 (pt) 1998-04-29 1999-04-23 composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto.

Country Status (33)

Country Link
US (2) US6313136B1 (pt)
EP (4) EP1073656B1 (pt)
JP (2) JP3883383B2 (pt)
KR (3) KR100595806B1 (pt)
CN (2) CN1174980C (pt)
AR (2) AR015768A1 (pt)
AT (4) ATE372339T1 (pt)
AU (2) AU769190B2 (pt)
BR (2) BR9909996B1 (pt)
CA (2) CA2329922C (pt)
CZ (2) CZ292567B6 (pt)
DE (4) DE69937076T2 (pt)
DK (2) DK1073656T3 (pt)
EE (2) EE04676B1 (pt)
ES (2) ES2252975T3 (pt)
HU (2) HUP0102313A3 (pt)
ID (2) ID26819A (pt)
IL (4) IL139200A0 (pt)
IS (2) IS5683A (pt)
MY (2) MY121389A (pt)
NO (2) NO318203B1 (pt)
NZ (2) NZ507638A (pt)
PL (2) PL195000B1 (pt)
RU (2) RU2238271C2 (pt)
SA (2) SA99200064B1 (pt)
SE (1) SE9801526D0 (pt)
SI (1) SI1073656T1 (pt)
SK (2) SK285768B6 (pt)
TR (4) TR200003149T2 (pt)
TW (2) TW490466B (pt)
UA (2) UA67769C2 (pt)
WO (2) WO1999055706A1 (pt)
ZA (2) ZA200005796B (pt)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9802794D0 (sv) * 1998-08-21 1998-08-21 Astra Ab New compounds
US6900324B2 (en) 2000-09-07 2005-05-31 Astrazeneca Ab Process for preparing a substituted imidazopyridine compound
SE0003186D0 (sv) * 2000-09-07 2000-09-07 Astrazeneca Ab New process
UA80393C2 (uk) 2000-12-07 2007-09-25 Алтана Фарма Аг Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці
SE0100295D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100296D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
SE0100297D0 (sv) * 2001-02-01 2001-02-01 Astrazeneca Ab New compounds
ATE324871T1 (de) * 2001-02-13 2006-06-15 Astrazeneca Ab Neue formulierung mit modifizierter freisetzung
US20040082605A1 (en) * 2001-03-08 2004-04-29 Arne Eek Use
SE0102808D0 (sv) * 2001-08-22 2001-08-22 Astrazeneca Ab New compounds
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
SE0201940D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination II
SE0201939D0 (sv) * 2002-06-20 2002-06-20 Astrazeneca Ab New combination
CA2499639C (en) 2002-09-19 2011-11-08 Schering Corporation Imidazopyridines as cyclin dependent kinase inhibitors
EA008304B1 (ru) 2002-11-19 2007-04-27 Алтана Фарма Аг 8-замещённые имидазопиридины
AR043002A1 (es) * 2003-02-18 2005-07-13 Altana Pharma Ag Imidazopirazinas 6-substituidos
DK1603570T5 (da) * 2003-02-26 2013-12-09 Sugen Inc Aminoheteroarylforbindelser som proteinkinaseinhibitorer
ES2335498T3 (es) 2003-03-10 2010-03-29 Nycomed Gmbh Nuevo proceso para la preparacion de reflumilast.
SE525349C2 (sv) * 2003-06-23 2005-02-08 Volvo Penta Ab Utombordsdrev för båtar
SE0301904D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound II with therapeutic effect
SE0301903D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound III with therapeutic effect
SE0301905D0 (sv) * 2003-06-26 2003-06-26 Astrazeneca Ab Novel imidazopyridine compound I with therapeutic effect
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2544325A1 (en) * 2003-11-03 2005-05-12 Astrazeneca Ab Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux
SE0303451D0 (sv) * 2003-12-18 2003-12-18 Astrazeneca Ab New compounds
EP1711498A2 (en) * 2004-01-26 2006-10-18 Altana Pharma AG 1,2,4-triazolo¬1,5-a|pyridines as gastric acid secretion inhibitors
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
WO2006064339A1 (en) * 2004-12-17 2006-06-22 Pfizer Japan Inc. Chromane derivatives useful as acid pump antagonists
EP2258350B1 (en) 2005-03-16 2014-12-24 Takeda GmbH Taste masked dosage form containing roflumilast
US7666880B2 (en) 2005-03-21 2010-02-23 S*Bio Pte Ltd. Imidazo[1,2-A]pyridine derivatives: preparation and pharmaceutical applications
CN101218238B (zh) * 2005-03-21 2011-10-26 S*Bio私人有限公司 咪唑并[1,2-a]吡啶衍生物:制备及药学应用
WO2006100119A1 (en) * 2005-03-24 2006-09-28 Glaxo Group Limited Derivatives of imidazo (1,2-a) pyridine useful as medicaments for treating gastrointestinal diseases
GB0513423D0 (en) * 2005-06-30 2005-08-03 Glaxo Group Ltd Novel compounds
DK1963302T3 (da) * 2005-12-05 2013-04-02 Pfizer Prod Inc Polymorfer af en C-MET/HGFR-inhibitor
US7825137B2 (en) * 2005-12-05 2010-11-02 Pfizer Inc. Method of treating abnormal cell growth
KR20080108129A (ko) * 2006-03-17 2008-12-11 라퀄리아 파마 인코포레이티드 크로메인 유도체
EP2054036B1 (en) 2006-07-24 2019-12-18 Singh-Broemer and Company, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
WO2008059373A1 (en) * 2006-11-17 2008-05-22 Raqualia Pharma Inc. Imidazo [1, 2-a] pyrazine derivatives and their use as acid pump antagonists
WO2009122435A2 (en) * 2008-03-31 2009-10-08 Council Of Scientific & Industrial Research A simultaneous method for the preparation of a mixture of 3- acetoxy-17-acetamido-16-formyl-androst-5,17-diene and 3- acetoxy-2'-chloro-5-androsteno[17,16-b]pyridine
FI20086158A0 (fi) * 2008-12-03 2008-12-03 Mikael Dahlstroem Imidatsopyridiinijohdannaiset
AU2014201644B2 (en) * 2008-12-03 2015-05-21 Cinclus Pharma Holding AB (publ) Imidazopyridine derivatives which inhibit the secretion of gastric acid
RU2403904C1 (ru) * 2009-02-26 2010-11-20 Федеральное государственное учреждение "Научно-исследовательский институт по изучению лепры Федерального агентства по здравоохранению и социальному развитию Росздрава" Способ профилактики острых гастродуоденальных язв у больных колоректальным раком в раннем послеоперационном периоде
MX2012000275A (es) * 2009-07-09 2012-02-08 Raqualia Pharma Inc Antagonista de bomba de acido para el tratamiento de enfermedades involucradas en la motilidad gastrointestinal anormal.
MX363456B (es) * 2013-06-25 2019-03-25 Hoffmann La Roche Compuestos para tratar atrofia muscular espinal.
JP6616772B2 (ja) 2013-12-16 2019-12-04 アサナ・バイオサイエンシズ,リミテッド・ライアビリティ・カンパニー P2x3および/またはp2x2/3化合物ならびに方法
CA2938923A1 (en) * 2014-03-24 2015-10-01 Arqule Inc. Process of preparing 3-(3-(4-(1-aminocyclobutyl)phenyl)-5-phenyl-3h-imidazo[4,5-b]pyridin-2-yl)pyridin-2-amine
CN106279151A (zh) * 2015-06-26 2017-01-04 江苏太瑞生诺生物医药科技有限公司 5-(2-(8-((2,6-二甲基苄基)氨基)-2,3-二甲基咪唑并[1,2-a]吡啶-6-甲酰胺基)乙氧基)-5-氧代戊酸的固体形式及其制备方法
KR101777971B1 (ko) * 2016-07-05 2017-09-12 제일약품주식회사 이미다조[1,2-a]피리딘 유도체, 이의 제조방법 및 이의 용도
KR20190057569A (ko) * 2017-11-20 2019-05-29 제일약품주식회사 7-아미노-1h-인돌-5-카르복사미드 유도체 및 이의 용도
EP3749697A4 (en) 2018-02-05 2021-11-03 Bio-Rad Laboratories, Inc. CHROMATOGRAPHY RESIN WITH LIGAND MIXED MODE ANIONIC / HYDROPHOBIC EXCHANGE
WO2019197232A1 (de) 2018-04-10 2019-10-17 Bayer Aktiengesellschaft Verfahren zur herstellung von 2,6-dialkylphenyl-essigsäuren
RU2732297C2 (ru) * 2018-11-14 2020-09-15 Общество с ограниченной ответственностью "Гурус БиоФарм" Производные нестероидных противовоспалительных средств
WO2021089580A1 (en) 2019-11-04 2021-05-14 Cinclus Pharma Ag Oral formulation of x842
CN118414334A (zh) 2021-11-05 2024-07-30 辛克鲁斯制药控股有限公司 (Publ) 谷氨酸利那拉生甲磺酸盐的多晶型物
AU2022381536A1 (en) 2021-11-05 2024-05-02 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
KR102496869B1 (ko) * 2022-07-29 2023-02-07 제일약품주식회사 이미다조[1,2-a]피리딘 화합물의 신규 염, 이의 결정형 및 제조방법
WO2024149833A1 (en) 2023-01-11 2024-07-18 Cinclus Pharma Holding AB (publ) Polymorphs of the maleic acid salt of linaprazan glurate
KR20250132529A (ko) 2023-01-11 2025-09-04 싱클루스 파마 홀딩 에이비 (피유비엘) 리나프라잔 글루레이트의 하이드로브로마이드 염의 다형체
EP4659742A1 (en) * 2023-02-01 2025-12-10 Jeil Pharmaceutical Co., Ltd. Pharmaceutical formulation, preparation method therefor, and tablet composition
WO2025215593A1 (en) * 2024-04-12 2025-10-16 Hetero Labs Limited An improved process for preparation of zastaprazan

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA81219B (en) * 1980-01-23 1982-01-27 Schering Corp Imidazo (1,2-a) pyridines ,process for their preparation and pharmaceutical compositions containing them
DE3269604D1 (en) * 1981-06-26 1986-04-10 Schering Corp Novel imidazo(1,2-a)pyridines and pyrazines, processes for their preparation and pharmaceutical compositions containing them
US4725601A (en) * 1985-06-04 1988-02-16 Fujisawa Pharmaceutical Co., Ltd. Certain imidazo[1,2-a]pyridines useful in the treatment of ulcers
EP0228006A1 (en) * 1985-12-16 1987-07-08 Fujisawa Pharmaceutical Co., Ltd. Imidazopyridine compounds and processes for preparation thereof
GB8722488D0 (en) * 1987-09-24 1987-10-28 Fujisawa Pharmaceutical Co Imidazopyridine compound
GB9102997D0 (en) * 1991-02-13 1991-03-27 Pfizer Ltd Therapeutic agents
GB9107513D0 (en) * 1991-04-10 1991-05-29 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof

Also Published As

Publication number Publication date
KR20010043134A (ko) 2001-05-25
EP1073657A1 (en) 2001-02-07
ZA200005797B (en) 2002-01-18
DE69928792D1 (de) 2006-01-12
SK14912000A3 (sk) 2001-06-11
HUP0102425A2 (hu) 2001-11-28
NO20005450D0 (no) 2000-10-27
ZA200005796B (en) 2002-01-18
HK1071139A1 (en) 2005-07-08
ATE372340T1 (de) 2007-09-15
PL343801A1 (en) 2001-09-10
TR200102612T2 (tr) 2002-06-21
WO1999055705A1 (en) 1999-11-04
EE04676B1 (et) 2006-08-15
EE200000664A (et) 2002-04-15
EP1491542B1 (en) 2007-09-05
JP2002513024A (ja) 2002-05-08
BR9909996A (pt) 2000-12-26
CN1307577A (zh) 2001-08-08
TWI250159B (en) 2006-03-01
KR20010043133A (ko) 2001-05-25
ATE312101T1 (de) 2005-12-15
UA66846C2 (uk) 2004-06-15
HK1036984A1 (en) 2002-01-25
IL139297A0 (en) 2001-11-25
BR9909995B1 (pt) 2010-07-13
US6313137B1 (en) 2001-11-06
PL195000B1 (pl) 2007-07-31
AU769108B2 (en) 2004-01-15
SK14922000A3 (sk) 2001-06-11
EP1073656B1 (en) 2005-10-19
SI1073656T1 (sl) 2006-02-28
WO1999055706A1 (en) 1999-11-04
EE04916B1 (et) 2007-10-15
HUP0102313A2 (hu) 2001-12-28
PL343797A1 (en) 2001-09-10
EE200000626A (et) 2002-04-15
DE69937076D1 (de) 2007-10-18
ID26819A (id) 2001-02-15
CN1165535C (zh) 2004-09-08
DE69927803T2 (de) 2006-07-06
RU2238271C2 (ru) 2004-10-20
CA2329922A1 (en) 1999-11-04
SE9801526D0 (sv) 1998-04-29
NZ507638A (en) 2003-10-31
CZ20003981A3 (cs) 2001-03-14
CZ292567B6 (cs) 2003-10-15
EP1491543A1 (en) 2004-12-29
JP3692034B2 (ja) 2005-09-07
KR100595805B1 (ko) 2006-07-03
CN1306533A (zh) 2001-08-01
KR20050121760A (ko) 2005-12-27
TR200102728T2 (tr) 2002-06-21
ID27530A (id) 2001-04-12
KR100650472B1 (ko) 2006-11-28
US6313136B1 (en) 2001-11-06
ES2249913T3 (es) 2006-04-01
CZ20003982A3 (cs) 2001-02-14
NO318203B1 (no) 2005-02-14
CA2329922C (en) 2006-04-11
SK285768B6 (sk) 2007-07-06
DE69937077T2 (de) 2008-05-29
JP3883383B2 (ja) 2007-02-21
DE69927803D1 (de) 2006-03-02
BR9909995A (pt) 2000-12-26
DK1073657T3 (da) 2006-03-13
NO317262B1 (no) 2004-09-27
NZ507639A (en) 2004-01-30
IL139200A0 (en) 2001-11-25
KR100595806B1 (ko) 2006-07-03
MY121389A (en) 2006-01-28
NO20005450L (no) 2000-12-22
UA67769C2 (uk) 2004-07-15
CA2329921A1 (en) 1999-11-04
AR015769A1 (es) 2001-05-16
DE69937076T2 (de) 2008-05-29
TR200003176T2 (tr) 2001-03-21
DE69928792T2 (de) 2006-07-20
AU4300799A (en) 1999-11-16
HK1033317A1 (en) 2001-08-24
AR015768A1 (es) 2001-05-16
SA99200064B1 (ar) 2006-10-11
AU4300699A (en) 1999-11-16
TR200003149T2 (tr) 2001-03-21
AU769190B2 (en) 2004-01-22
HK1033457A1 (en) 2001-08-31
HUP0102313A3 (en) 2002-10-28
ES2252975T3 (es) 2006-05-16
JP2002513025A (ja) 2002-05-08
EP1491542A2 (en) 2004-12-29
EP1491543B1 (en) 2007-09-05
IL139297A (en) 2007-06-03
ATE372339T1 (de) 2007-09-15
CN1174980C (zh) 2004-11-10
EP1491542A3 (en) 2005-01-05
HUP0102425A3 (en) 2002-12-28
DK1073656T3 (da) 2006-01-16
HK1036981A1 (en) 2002-01-25
RU2235725C2 (ru) 2004-09-10
TW490466B (en) 2002-06-11
NO20005451D0 (no) 2000-10-27
WO1999055706A9 (en) 2000-03-16
SA99200065A (ar) 2005-12-03
NO20005451L (no) 2000-12-27
DE69937077D1 (de) 2007-10-18
EP1073656A1 (en) 2001-02-07
IS5683A (is) 2000-10-25
CZ293977B6 (cs) 2004-09-15
EP1073657B1 (en) 2005-12-07
IL139200A (en) 2010-04-29
MY121379A (en) 2006-01-28
SA99200065B1 (ar) 2006-11-07
ATE307130T1 (de) 2005-11-15
IS5684A (is) 2000-10-25

Similar Documents

Publication Publication Date Title
BR9909996B1 (pt) composto derivado de imidazo piridina, processo para a preparaÇço de um composto, formulaÇço farmacÊutica, e, uso de um composto.
BR9807814B1 (pt) composto de pirazina, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9912109B1 (pt) compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto.
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9810802B1 (pt) composto, composição farmacêutica, e, processo para a preparação de um composto.
BR9806870B1 (pt) composto amidino, formulação farmacêutica, uso de um composto, e, processo papa preparar o mesmo.
BR9810829B1 (pt) composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
BR9501770A (pt) Uso de um composto,composto,formulação farmacêutica e processo para preparar um composto
BR0113494B1 (pt) processo para a preparaÇço de uma formulaÇço sàlida herbicida, e, uso de uma formulaÇço sàlida herbicida.
BR9801606B1 (pt) composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica.
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
NO986023L (no) Vannbasert, farmas°ytisk preparat
BR0009083B1 (pt) derivado de amida compreendendo um núcleo de quinazolinona, processo para a preparação de um derivado de amida, composição farmacêutica, e, uso de um derivado de amida.
BR9909925B1 (pt) derivados de quinolina, composições farmacêuticas, e, processo para a fabricação de derivados de quinolina.
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
EE04721B1 (et) Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine
BR9711311B1 (pt) derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos.
BR9912104B1 (pt) compostos derivados de quinolina, composições farmacêuticas, e, processo para a manufatura de um composto.
BR9404809A (pt) Composto, uso, formulação farmacêutica e processo para preparar um composto
BR9803720B1 (pt) composto de pigmento de quinoxalina-monoazo-acetarilida, processo para a preparação e uso do mesmo.
EE04151B1 (et) Atsüülpiperasinüülpürimidiinide derivaadid, nendevalmistamine ja kasutamine ravimitena
EE9800265A (et) Erütromütsiini derivaadid, nende valmistamismeetod ja kasutamine ravimitena
PT1165081E (pt) Processo para a preparacao de preparacoes farmaceuticas cintendo tolperisona, para administracao oral
EE03825B1 (et) 2-tsüanoiminoimidasooli derivaadid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid
EE04346B1 (et) Asoolid, nende valmistamismeetod, kasutamine ja farmatseutiline kompositsioon

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]

Free format text: REFERENTE A RPI 1995 DE 31/03/2009.

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/08/2010, OBSERVADAS AS CONDICOES LEGAIS.

B24C Patent annual fee: request for for restoration

Free format text: REFERENTE A 12A E 13A ANUIDADE.

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE AS 12A, 13A, 14A, 15A E 16A ANUIDADES. PAGAR RESTAURACAO.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.